— Know what they know.
Not Investment Advice

OPRX

OptimizeRx Corporation
1W: +13.8% 1M: -6.0% 3M: -46.0% YTD: -42.2% 1Y: -20.2% 3Y: -43.8% 5Y: -85.6%
$7.18
+0.40 (+5.90%)
After Hours: $7.31 (+0.13, +1.88%)
NASDAQ · Healthcare · Medical - Healthcare Information Services · $134.7M · Alpha Radar Strong Sell · Power 39
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$134.7M
52W Range5.54-22.25
Volume1,729,564
Avg Volume397,816
Beta1.24
Dividend
Analyst Ratings
11 Buy 4 Hold 0 Sell
Consensus Buy
Company Info
CEOStephen L. Silvestro
Employees128
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2007-11-28
400 Water Street
Waltham, MI 48307
US
248 651 6568
About OptimizeRx Corporation

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Recent Insider Trades

NameTypeSharesPriceDate
Odence-Ford Marion M-Exempt 4,000 2026-02-11
Odence-Ford Marion F-InKind 1,386 $9.23 2026-02-11
Odence-Ford Marion M-Exempt 4,000 2026-02-11
Greco Theresa F-InKind 1,420 $12.74 2025-12-23
Silvestro Stephen L F-InKind 3,361 $12.74 2025-12-23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms